A formal prescription isn’t currently required due to restrictions placed on families during quarantine, but parents should talk with their child’s physician before use.
, is one of several low-risk, clinically validated therapeutics that is now being made available, though without formal FDA clearance, for a limited time during the crisis.Akili has been working with the FDA on approval of Endeavor™ as a prescription treatment for use in pediatric ADHD. The treatment has been evaluated in more than 600 children withEndeavor™ is based on a game called NeuroRacer, which was designed by neuroscientist Adam Gazzaley, M.D., Ph.D.
Endeavor™ is available to families of children aged 8-12 who have been diagnosed with ADHD. Anyone that is eligible — per clinical indication and instructions for use — can access Endeavor™ and have the cost waived for a limited time. At this time, Endeavor™ is only available in the United States.“Enforcement Policy for Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019 Public Health Emergency.”https://www.fda.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
\u201cThere\u2019s No Way I Could Have ADHD, Right?!?\u201d'I was always telling myself that I was a failure. Stupid. Worthless. An ADHD diagnosis has added a key piece of the puzzle that has helped me realize that there’s a reason behind these behaviors, and there are ways to cope.'
Read more »
\u201c7 Reasons Why People with ADHD Should Work from Home\u201dRaise your hand if you have ADHD and have ever honestly thought you might die in a long meeting... or a noisy cubicle... or an afternoon brainstorming session without end.
Read more »
FDA Approves Female-Libido-Enhancing ManWASHINGTON—In an effort to address the needs of women suffering from a lack of sexual desire, the FDA announced Tuesday that it had approved a new female-libido-enhancing man, which is expected to be made available to the general public by year’s end. “After conducting numerous trials on hundreds of female subjects with low sex drives, we determined that this man significantly increased sexual interest among women of all ages,” said FDA representative Jane Newlon, who noted that using the 75kg man, known as Gabriel, every day had been shown to activate the regions of the brain associated with pleasure, increase blood flow to the genitals, and boost instances of orgasm by almost 40 percent. “We observed a sharp rise in libido immediately after the man is introduced, with stimulative effects lasting for up to four hours at a time. In a marketplace dominated by male-libido-enhancing products, it is a significant milestone to finally have a safe, effective option for women who want to increase their arousal, and that is exactly what this man offers.” Newlon went on to warn consumers that when mixed with alcohol, the man becomes much less effective.
Read more »
Infectious Disease Expert: FDA Has 'All But Given Up' Oversight On Antibody Testing'We have the wild, wild West for testing right now,' said Dr. Michael Osterholm.
Read more »
F.D.A. Warns of Heart Problems From Malaria Drugs Used for Coronavirus'The drugs can cause dangerous abnormalities in heart rhythm in coronavirus patients, and should be used only in clinical trials or hospitals where patients can be closely monitored for heart problems, the Food and Drug Administration warned.'
Read more »